Tag: pharmaceuticals
Big Pharma Should Curb Drug Price Increases During Pandemic, Consumer Group...
A consumer group calls on pharmaceutical companies to freeze drug prices during the COVID-19 pandemic and says the U.S. government should regulate...
First AI-Designed Drug Enters Testing, Raising Hopes for Faster, Cheaper Drug...
A drug developed using artificial intelligence will enter clinical trials for the first time, opening up the possibility of using machine learning...
China’s Spreading Coronavirus May Ripple, Disrupting Global Supply Chains of Medicines...
The novel coronavirus that is spreading in China may harm the health of more than those who catch the respiratory illness —...
As Drug-Resistant Bacteria Frustrates Big Pharma, Impact Investors See Opportunities
With more than 500,000 people dying each year due to their bodies rejecting currently available antibiotics, profits are drying up and the...
Novartis $2M Drug For Killer Genetic Disease to Be Dispensed for...
It’s the world’s most expensive drug, and one of only two available for spinal muscular atrophy, the top genetic killer of children...
Private Equity, Biotech Industry Worried Pelosi Drug Plan Would Be ‘Destructive,’...
Private equity and venture capital firms, which have poured billions of dollars in biotech firms, are opposing House Speaker Nancy Pelosi’s plan...
Magnetar Raising $400 Million for Healthcare Fund as Private Money Piles...
Magnetar Capital, which has made billions on its energy and infrastructure bets, is joining others who are seeing green lights flashing in...
Seniors May Be Overpaying for Medicine, Study Looking at Medicare’s Use...
Medicare may not be getting the best prescription drug deals it can, meaning senior citizens using the plan are overpaying, a new...
Purdue Pharma Took a Page from Big Tobacco & Oil in...
Oxycontin maker Purdue Pharma cultivated sympathetic writers and funded think tanks as part of an aggressive media campaign aimed at countering negative...
Government Lawsuit Against Gilead Highlights Steep Cost of HIV Prevention Pills
A lawsuit filed by the Trump administration against Gilead Sciences is the most direct action taken to date to bring down the...
FDA Will Consider Biogen’s Controversial Drug as First New Alzheimer’s Treatment...
A controversial drug that treats the early stages of Alzheimer’s disease might become the first medication for the disease in 17 years...
U.S. Wants More Domestic Pharma Production as Quality Concerns Persist; Lawmakers...
As concerns rise about the growing percentage of U.S. drugs manufactured in China, U.S legislators are seeking measures to bring more of...
Bristol-Myers Partners with Accelerator BioMotiv to Develop New Drugs
Pharmaceutical giant Bristol-Myers Squibb will become a limited partner in BioMotiv, a Cleveland-based biotech accelerator, to jointly fund new research into therapies...
Glycomine Lands $33 Million for Trials of Therapy for Rare Genetic...
With a goal to stamp out a rare disease that takes the lives of about one-fifth of the children it affects, biotechnology...
Startups Using Agility, Experience, to Move the Needle on Opioid Crisis
From a social network for addicts to robots that test sewage water for traces of drugs, startups and private companies are applying...
Eisai Tries to Bounce Back With New Dementia Approach
Eisai Inc. opened an incubator for research into Alzheimer’s and other diseases as part of its new dementia research center, as it...
BioNTech, Melding AI, Robotics and Biotech, Nets $325 Million for Vaccine...
German start-up BioNTech raised $325 million in private funding, one of the largest hauls for a European biopharma company, which will help...
Chinese Gut Bacteria Developer Xbiome Has Raised $10 Million for Clinical...
Xbiome, which calls itself China’s first AI-based company that specializes in the development of gut microbiome, has raised a total of about...
CMS Medical Buys 25% of Midatech’s Outstanding Stock
On Our Radar: Deals we are paying attention to for their impact on industry.
CMS Medical Venture Investment has bought a quarter of Midatech Pharma Plc’s...